Sara Mangsbo
Corporate Officer/Principal bei ULTIMOVACS ASA
Profil
Sara Mangsbo is the founder of Immuneed AB, where she holds the title of Director & Chief Scientific Officer since 2014.
She is also the founder of Strike Pharma AB, where she holds the title of Chief Scientific Officer & Director since 2020.
Dr. Mangsbo is also the founder of VivoLogica AB.
Currently, she is the Chief Innovation Officer at Ultimovacs ASA.
Aktive Positionen von Sara Mangsbo
Unternehmen | Position | Beginn |
---|---|---|
ULTIMOVACS ASA | Corporate Officer/Principal | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Gründer | 01.01.2014 |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Gründer | 10.12.2020 |
Ehemalige bekannte Positionen von Sara Mangsbo
Unternehmen | Position | Ende |
---|---|---|
VivoLogica AB
VivoLogica AB Packaged SoftwareTechnology Services VivoLogica AB specializes in providing a comprehensive tool for data collection, analysis, compliance, and reporting for research purposes. The company is based in Stockholm, Sweden. The Swedish company offers a platform that enables researchers to have full control over their research data and provides scientific output in one tool. The company was founded by Sara Mangsbo, and the CEO is Martina Banyay. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Private Unternehmen | 3 |
---|---|
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Health Technology |
Strike Pharma AB
Strike Pharma AB Miscellaneous Commercial ServicesCommercial Services Strike Pharma AB is a Swedish company that specializes in developing therapeutic vaccines for solid tumors. The company is based in Uppsala, Sweden and was founded in 2020 by Pierre Dönnes and Sara Mangsbo. The company utilizes ADAC technology to create personalized immunotherapy for their patients. Mårten Winge has been the CEO of the company since 2021. | Commercial Services |
VivoLogica AB
VivoLogica AB Packaged SoftwareTechnology Services VivoLogica AB specializes in providing a comprehensive tool for data collection, analysis, compliance, and reporting for research purposes. The company is based in Stockholm, Sweden. The Swedish company offers a platform that enables researchers to have full control over their research data and provides scientific output in one tool. The company was founded by Sara Mangsbo, and the CEO is Martina Banyay. | Technology Services |